Pain News and Research

Latest Pain News and Research

Women with early-stage breast cancer do not benefit from lymph node removal

A new study shows that removing lymph nodes due to the presence of occult, or microscopic, cancer cells found in the sentinel lymph node - the one closest to the tumor -- has no impact on survival outcomes of women with early-stage breast cancer.

27 Jul 2011

Cocaine-free topical anaesthetics can effectively treat pain caused by torn skin

While some pain killers need to be injected into the damaged tissue in order to work, topical anaesthetics only need to be spread on the surface. The earliest examples of "topical" anaesthetics contained cocaine, but now a new systematic review has shown that newer agents that don't contain cocaine can effectively treat pain caused by torn skin.

27 Jul 2011

High-dose vitamin D reduces musculoskeletal pain in breast cancer patients

High-dose vitamin D relieves joint and muscle pain for many breast cancer patients taking estrogen-lowering drugs, according to a new study from Washington University School of Medicine in St. Louis.

27 Jul 2011

Watson second quarter net revenue increases 24% to $1.1 billion

Watson Pharmaceuticals, Inc. today reported net revenue of $1.1 billion for the second quarter ended June 30, 2011, an increase of 24 percent when compared to $875.3 million in the second quarter 2010.

26 Jul 2011

First Edition: July 26, 2011

In her latest Kaiser Health News consumer column, Michelle Andrews writes: "In the controlled chaos of an hospital emergency department, ensuring that patients are pain-free and can make informed choices about their care often takes a back seat to assessing and stabilizing them and moving them through the system as fast as possible.

26 Jul 2011

Tumor marker, endoscopic ultrasound more likely to detect stage 1 pancreatic cancer

Researchers from New England report in a new study that using a tumor marker, serum CA 19-9, combined with an endoscopic ultrasound if the tumor marker is elevated, is more likely to detect stage 1 pancreatic cancer in a high-risk population than by using the standard means of detection.

26 Jul 2011

Diabetes drug rosiglitazone can reduce development of neuropathic pain

The diabetes drug rosiglitazone (Avandia) can control inflammation leading to nerve damage and abnormal pain responses, suggests a paper in the August issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

26 Jul 2011

Fluoride supplements neither safe or effective

Sodium fluoride supplements "have not been found by FDA to be safe or effective," according to the U.S. National Library of Medicine's website, reports the New York State Coalition Opposed to Fluoridation, Inc..

25 Jul 2011

QRxPharma raises A$25 million, announces A$10.4 million Rights Issue

QRxPharma Limited is pleased to announce the successful completion of a placement to institutions and professional investors raising A$25 million which was significantly oversubscribed. The Placement was very well supported by both existing and new investors including Australia, US and UK based fund managers.

25 Jul 2011

Safety tips to avoid backpack injuries

Backpacks are a common ingredient on back-to-school lists. Unfortunately, they are a leading cause of back and shoulder pain for millions of school children across the nation. As students gear up for back-to-school this fall, Minnesota chiropractors would like to offer parents ways to help children avoid backpack injuries.

25 Jul 2011

BDSI completes BEMA Buprenorphine Phase 3 trial on chronic pain

BioDelivery Sciences International, Inc. announced today that the last patient has completed the randomized portion of its Phase 3 clinical trial assessing the efficacy and safety of BEMA Buprenorphine for the treatment of moderate to severe chronic pain, signifying completion of the trial.

25 Jul 2011

Intravenous fluids appear to lower severity of kidney failure in children with E. coli infection

Infection with E. coli bacteria can wreak havoc in children, leading to bloody diarrhea, fever and kidney failure. But giving children intravenous fluids early in the course of an E. coli O157:H7 infection appears to lower the odds of developing severe kidney failure, according to researchers at Washington University School of Medicine in St. Louis and other institutions.

25 Jul 2011

Catholic Church apologizes for past forced adoption practices

According to the head of the healthcare arm of the Catholic Church, they are prepared to apologize to the victims of forced adoption practices dating back 50 years. The Catholic Health Australia admits that “a small number” of church-run hospitals and women's homes maintained unwanted adoption practices from the 1950s to the 1970s.

24 Jul 2011

Homeless people report using street drugs to treat their pain

Chronic pain is not managed well in the general population and it's an even greater challenge for homeless people, according to new research by St. Michael's Hospital.

22 Jul 2011

The Joint Commission certifies 7 disease-specific programs at Children's Medical Center

The Joint Commission has certified seven disease-specific programs at Children's Medical Center Dallas, www.childrens.com. Children's is the only pediatric hospital in the United States with more than two such designations of excellence, making the Dallas hospital a leader in health care reform.

22 Jul 2011

Study finds high prevalence of prescription pain medication addiction in chronic patients

A new study by Geisinger Health System researchers finds a high prevalence of prescription pain medication addiction among chronic pain patients.

22 Jul 2011

FDA approves Cephalon's REMS for FENTORA, ACTIQ

Cephalon, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved the Risk Evaluation and Mitigation Strategy (REMS) for FENTORA and ACTIQ.

22 Jul 2011

Roundup: Ore. cuts insurer's rate increase; Ga.'s effort to curb TB struggles; psychiatric care hard to get in Boston

The Oregon Insurance Division will allow the state's largest health insurer to raise rates on individual premiums an average 12.8 percent, far lower than the 22.1 percent the company had requested.

22 Jul 2011

Enrollment complete in Sapheon's clinical study of saphenous vein reflux disease treatment

Sapheon Inc. announced successful enrollment in a 30-patient, prospective, single-arm clinical study of the Sapheon Closure System — a single-use, minimally invasive approach to the treatment of saphenous vein reflux disease.

22 Jul 2011

FDA approves Boca Pharmacal's Hydrocodone Bitartrate and Acetaminophen Oral Solution ANDA

Boca Pharmacal, Inc., today announced that it has received approval from the FDA of its Abbreviated New Drug Application (ANDA) for Hydrocodone Bitartrate and Acetaminophen Oral Solution, 7.5mg / 325mg per 5mL, the generic version of Hycet Oral Solution distributed by FSC Laboratories, Inc.

22 Jul 2011

Pain News and Research

Latest Pain News and Research

Women with early-stage breast cancer do not benefit from lymph node removal

Cocaine-free topical anaesthetics can effectively treat pain caused by torn skin

High-dose vitamin D reduces musculoskeletal pain in breast cancer patients

Watson second quarter net revenue increases 24% to $1.1 billion

First Edition: July 26, 2011

Tumor marker, endoscopic ultrasound more likely to detect stage 1 pancreatic cancer

Diabetes drug rosiglitazone can reduce development of neuropathic pain

Fluoride supplements neither safe or effective

QRxPharma raises A$25 million, announces A$10.4 million Rights Issue

Safety tips to avoid backpack injuries

BDSI completes BEMA Buprenorphine Phase 3 trial on chronic pain

Intravenous fluids appear to lower severity of kidney failure in children with E. coli infection

Catholic Church apologizes for past forced adoption practices

Homeless people report using street drugs to treat their pain

The Joint Commission certifies 7 disease-specific programs at Children's Medical Center

Study finds high prevalence of prescription pain medication addiction in chronic patients

FDA approves Cephalon's REMS for FENTORA, ACTIQ

Roundup: Ore. cuts insurer's rate increase; Ga.'s effort to curb TB struggles; psychiatric care hard to get in Boston

Enrollment complete in Sapheon's clinical study of saphenous vein reflux disease treatment

FDA approves Boca Pharmacal's Hydrocodone Bitartrate and Acetaminophen Oral Solution ANDA

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Pain News and Research

Latest Pain News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in